Modelling and drug screening for cardiovascular disease

Research output: Contribution to journalSpecial issueAcademicpeer-review

1 Downloads (Pure)

Abstract

Special Issue:
Abstracts of the 96th Annual Meeting of the German Physiological Society, 16–18 March 2017, Greifswald, Germany
Original languageEnglish
Article numberSO2-2
Pages (from-to)7-7
JournalActa physiologica
Volume219
Issue numberS711
DOIs
Publication statusPublished - Mar 2017

Cite this

@article{bc74e683a0f64dd29715e7489e6d34a9,
title = "Modelling and drug screening for cardiovascular disease",
abstract = "Special Issue:Abstracts of the 96th Annual Meeting of the German Physiological Society, 16–18 March 2017, Greifswald, Germany",
author = "R. Passier",
year = "2017",
month = "3",
doi = "10.1111/apha.12866",
language = "English",
volume = "219",
pages = "7--7",
journal = "Acta physiologica",
issn = "1748-1708",
publisher = "Wiley-Blackwell",
number = "S711",

}

Modelling and drug screening for cardiovascular disease. / Passier, R.

In: Acta physiologica, Vol. 219, No. S711, SO2-2, 03.2017, p. 7-7.

Research output: Contribution to journalSpecial issueAcademicpeer-review

TY - JOUR

T1 - Modelling and drug screening for cardiovascular disease

AU - Passier, R.

PY - 2017/3

Y1 - 2017/3

N2 - Special Issue:Abstracts of the 96th Annual Meeting of the German Physiological Society, 16–18 March 2017, Greifswald, Germany

AB - Special Issue:Abstracts of the 96th Annual Meeting of the German Physiological Society, 16–18 March 2017, Greifswald, Germany

U2 - 10.1111/apha.12866

DO - 10.1111/apha.12866

M3 - Special issue

VL - 219

SP - 7

EP - 7

JO - Acta physiologica

JF - Acta physiologica

SN - 1748-1708

IS - S711

M1 - SO2-2

ER -